Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-CD40 ANTIBODIES AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/198194
Kind Code:
A1
Abstract:
This disclosure relates to anti-CD40 (TNF Receptor Superfamily Member 5) antibodies, antigen-binding fragments, and the uses thereof.

More Like This:
JP2022065094ANTI-VISTA ANTIBODIES AND FRAGMENTS
JP5818003Highly functional mutant of humanized anti-EGFR antibody variable region
WO/1994/005304ISOLATED NONAPEPTIDE DERIVED FROM MAGE-3 GENE AND PRESENTED BY HLA-A1, AND USES THEREOF
Inventors:
LIU YACUI (CN)
TIAN MAOPENG (CN)
YANG FANG (CN)
YANG YI (CN)
Application Number:
PCT/CN2023/088417
Publication Date:
October 19, 2023
Filing Date:
April 14, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C12N15/12
Domestic Patent References:
WO2020014974A12020-01-23
Foreign References:
AU2016201742A12016-04-07
CN103596593A2014-02-19
CN112334195A2021-02-05
US20100119516A12010-05-13
Other References:
HORTON,H.M. ET AL.: "Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies", BLOOD, vol. 116, no. 16, 21 October 2010 (2010-10-21), pages 3004 - 3012, XP009146207, DOI: 10.1182/blood-2010-01-265280
Attorney, Agent or Firm:
BEIJING LINKTEC IP LAW FIRM (SPECIAL GENERAL PARTNERSHIP) (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: WATER RECIRCULATION-TYPE GREENHOUSE

Next Patent: CONJUGATE COMPRISING TOLL-LIKE RECEPTOR AGONIST